MedPath

A study looking at the effectiveness of a oral herbal supplement for helping to manage the symptoms of enlarged prostate

Phase 2
Completed
Conditions
Benign Prostatic Hypertrophy
Alternative and Complementary Medicine - Herbal remedies
Renal and Urogenital - Other renal and urogenital disorders
Registration Number
ACTRN12610000168055
Lead Sponsor
Totally Natural Products
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
68
Inclusion Criteria

1. Male aged between 40-80 years
2. Medically diagnosed with benign prostatic hypertrophy
3. Minimum score of 8 on the IPSS

Exclusion Criteria

1. Use of a drug/natural therapy for BPH or other urological symptoms within 30 days of starting the trial.
2. Recently starting a bladder training program.
3. Urogenital surgery within the last 6 months.
4. A bladder biopsy and/or cystoscopy and biopsy within 30 days of starting the trial.
5. An indwelling catheter or practice of self-catheterisation.
6. Diagnosis of chronic persistant local pathology (i.e. interstitual cystitis, bladder stones).
7. Currently taking Warfarin or other anti-coagulant therapies.
8. Diagnosis of hypertension and recieving prescribed antihypertenive medications.
9. Diagnosis with severe renal and/or hepatic insufficiency.
10. Diagnosed with genital anatomical deformaties, uncontrolled diabetes, history of spinal cord injury and uncontrolled psychiatric disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A reduction in the International Prostate Symptom Score (IPSS) to assess efficacy of preparation on symptoms of benign prostatic hypertrophy[baseline<br>1 month<br>2 month<br>3 month]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath